A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of the study is to determine the efficacy of pegcetacoplan administration compared to placebo in increasing hemoglobin (Hgb) level from baseline and avoiding transfusion in participants with primary cold agglutinin disease (CAD).
Epistemonikos ID: a1e97ea5b01178b001eae40dde4c8e900aab9776
First added on: May 09, 2024